Anti-miillerian hormone: A unique biochemical marker of gonadal development and fertility in humans;Anti-Müllerovhormon: Jedinstveni biokemijskimarker razvojag nada i plodnosti

Biochemia Medica

Volumn 21, Issue 3, 2011, Pages 219-230

  Zec, Ivana ^a   Tislaric Medenjak, Dubravka ^a   Megia, Zeljka Bukovec ^a   Kucak, Ivana ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Anti miillerian hormone; Infertility; Ovarian reserve; Sex differentiation; Spermatogenesis

Indexed keywords

BUSULFAN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSINE; HORMONE RECEPTOR; INHIBIN B; MELPHALAN; MUELLERIAN INHIBITING FACTOR; MUELLERIAN INHIBITING FACTOR RECEPTOR; PROCARBAZINE; STEROID HORMONE; TAMOXIFEN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULTHOOD; AGING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CRYPTORCHISM; DNA POLYMORPHISM; FEMALE INFERTILITY; FERTILITY; GONAD DEVELOPMENT; GRANULOSA CELL; GRANULOSA CELL TUMOR; GROUPS BY AGE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; IMMUNOASSAY; INFANCY; INFERTILITY THERAPY; MENSTRUAL CYCLE; NONHUMAN; OVARIAN RESERVE; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PREGNANCY; PREMATURE OVARIAN FAILURE; PRENATAL DEVELOPMENT; PUBERTY; RADIATION SICKNESS; RECEPTOR BINDING; REVIEW; ROKITANSKY SYNDROME; SERTOLI CELL; SEX DIFFERENTIATION; SIDE EFFECT; SIGNAL TRANSDUCTION; SPERMATOGENESIS; BIOLOGICAL MODEL; BLOOD; CYTOLOGY; FEMALE; GONAD; GROWTH, DEVELOPMENT AND AGING; INFERTILITY; MALE; METABOLISM; PHYSIOLOGY;

AGING; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; FEMALE; FERTILITY; GONADS; HUMANS; INFERTILITY; MALE; MODELS, BIOLOGICAL; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 80054762028     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Wilson C, Clemente N, Ehrenfels C, Pepinsky R, Josso N, Vigier B, et al. Mullerian inhibiting substanee requires its N-terminal domain for maintenanee ofbiologieal aetivity, a novel finding within the transforming growth-faetor-beta superfamily. Mol Endoerinol 1993;7:247-57.
2. Pieard JY, Benaroust R, Guerrier D, Josso N, Khan A. Cloning and expression of eDNA for anti-Mullerian hormone. Proe Natl Aead Sei 1986;83:5464-8.
3. di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Ti-zard R, et al. Cloning, expression, and alternative splieing of the reeeptor for anti-Mullerian hormone. Mol Endoerinol 1994;8:1006-20.
4. Visser JA, Themmen APN. Anti-Mullerian hormone and folli-eulogenesis. Mol Cell Endoerinol 2005;234:81-6.
5. La Marea A, Volpe A. Anti-Mullerian hormone (AMH) in female reproduetion: is measurement of eireulating AMH a useful tool? Clin Endoerinol 2006;64:603-10.
6. Visser JA. AMH signalling from reeeptor to target gene. Mol Cell Endoerinol 2003;211:65-73.
7. Rhoades RA, Bell DR, eds. Medieal physiology: prineiples for elinieal medieine. 3rd ed. Baltimore, Philadelphia; Lippineott Wiliams&Wilkins;2009. p. 716-9.
8. Lee MM, Donahoe PK. Mullerian-inhibiting substanee: a gonadal hormone with multiple funetions. Endoer Rev 1993;14:152-64.
9. Grinspon RP, Rey RA. Anti-Mullerian hormone and Sertoli eell funetion in pediatrie male hypogonadism. Horm Res Paedia-tr 2010;73:81-92.
10. Rajpert-Demeyts E, Jorgensen N, Graem N, Muller J, Cate RL. Skakkebaek NE. Expression of anti-Mullerian hormone during normal and pathologiealgonadal development: association with differentiation of Sertoli and granulosa eells. J Clin Endoerinol Metab 1999;84:3836-44.
11. Speroff L, Glass RH, Kase NG in Clinieal Gyneeologie Endoe-rinology and Infertility. Mitehell C (ed.), Williams & Wilkins, Baltimore, Philadelphia, Hong Kong, Munieh, Sidney, Tokyo, 1994, p. 362-6.
12. Alviggi C, Humaidan P, Howles CM, Tredway D, Hillier SG. Bio-logieal versus ehronologieal ovarian age: implieations for assisted reproduetive teehnology. Available at: http://www.rbej.eom/eontent/7/1/10, Aeeessed September 22,2009.
13. Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, et al. Changes in Anti-Mullerian Hormone (AMH) throughout the Life Span: A Population-Based Study of 1027 Healthy Males from Birth (Cord Blood) to the Age of 69 Years. J Clin Endoerinol Metab 2010;95:5357-64.
14. Brito VN, Berger K, Bilharinho Mendonea B. Male hypogonadism: ehildhood diagnosis and future therapies. Pediatrie Health 2010;4:539-55.
15. Rey AR, Belville C, Nihoul-Fekete C, Miehel-Calemard L, Forest MG, Lahlou N. Evaluation of Gonadal Funetion in 107 Intersex Patients by Means of Serum Antimullerian Hormone Measurement. J Clin Endoerinol Metab 1999;84:627-31.
16. Marshall WA, TannerJM. Variations in pattern of pubertal ehanges in girls. Areh Dis Child 1969;44:291-303.
17. Wikström AM, Dunkel L. Testieular funetion in Klinefelter syndrome. Horm Res 2008;69:317-26.
18. Viswanathan V, Eugster EA. Etiology and treatment of hypogonadism in adoleseents. Endoerinol Metab Clin N Am 2009;38:719-38.
19. Tuttelmann F, Dykstra N, Themmen AP, Visser JA, Niesehlag E, Simoni M. Anti-Mullerian hormone in men with normal and redueed sperm eoneentration and men with maldeseended testes. Fertil Steril 2009;91:1812-9.
20. Belville C, Josso N, Pieard JY. Persistenee of Mullerian derivatives in males. Am J Med Genet 1999;89:218-23.
21. La Marea A, Broekmans FJ, Volpe A, Fauser BC, Maeklon NS. Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod 2009;24:2264-75.
22. Visser JA, de Jong FH, Laven JSE, Themmen APN. Anti-Mulle-rian hormone: a new marker for ovarian funetion. Available at: http://www.reproduetion-online.org/egi/reprint/131/1/1, Aeeessed June 20,2006.
23. Nilsson E, Rogers N, Skinner MK. Aetions of anti-Mullerian hormone on the ovarian transeriptome to inhibit primordial to primary folliele transition. Reproduetion 2007;134:209-21.
24. Andersen CY, Byskov AG. Estradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B seeretion: analysis of small antral and preovulatory human follieles'fluid. J Clin Endoerinol Metab 2006;91:4064-9.
25. Kevenaar ME, Themmen AP, Laven JS, Sonntag B, Fong SL, Uitterlinden AG, et al. Anti-Mullerian hormone and anti-Mullerian hormone type II reeeptor polymorphisms are asso-eiated with follieular phase estradiol levels in normo-ovula-tory women. Hum Reprod 2007;22:1547-54.
26. van Disseldorp J, Lambalk CB, Kwee J, Looman CWN, Eijke-mans MJC, Fauser BC, Broekmans FJ. Comparison of inter-and intra-eyele variability of anti-Mullerian hormone and an tral folliele eoun ts. Hum Reprod 2010;25:221-7.
27. Knauff EAH, Eijkemans MJC, Lambalk CB, ten Kate-Booij MJ, HoekA, Beerendonk CCM. Anti-Mullerian hormone, inhibin B, and antral folliele eount in young women with ovarian failure. J Clin Endoerinol Metab 2009;94:786-92.
28. La Marea A, Stabile G, Cardueei Artenisio A, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual eyele. Hum Reprod 2006;21:3103-7.
29. Tsepelidis S, Devreker F, Demeestere L, Flahaut A, Gerrvy C, Engelrt Y. Stable serum levels of anti-Mullerian hormone during the menstrual eyele: a prospeetive study in normo-ovu-latory women. Hum Reprod 2007;22:1837-40.
30. Seifer DB, Golub ET, Lambert-Messerlian G, Benning L, Anas-tos K, Watts D, et al. Variations in serum Mullerian inhibiting sub stan ee be tween whi te, bla ek and His pa nie women. Fer til Steril 2009;92:1674-8.
31. La Marea A, Giulini S, Orvieto R, De Leo V, Volpe A. An ti-Mulle-rian hormone eoneentrations in maternal serum during preg-naney. Hum Reprod 2005;20:1569-72.
32. Streuli I, Fraisse T, Chapron C, Bijaoui G, Bisehof P, deZiegler D. Serum antimullerian hormone levels remain stable throughout the menstrual eyele and after oral or vaginal administration of synthetie sex steroids. Fertil Steril 2008;90:395-400.
33. Steiner AZ. Clinieal implieations of ovarian reserve testing. Obstet Gyneeol Survey 2009;64:120-8.
34. Freeman EW, Graeia CR, Sammel MD, Lin H, Chong-Leong Lim L, Strauss IIIJF. Assoeiation of anti-mullerian hormone levels withobesity in late reproduetive-age women. Fertil Steril 2007;87:101-6.
35. La Marea A, Sighinolfi G, Radi D, Argento C, Baraldi E, Car-dueei Artenisio A, et al. Anti-Mullerian hormone (AMH) as a predietive marker in assisted reproduetive teehnology (ART). Hum Reprod Update 2009;16:113-30.
36. Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pem-berton P, etal. Cireulating basal anti-Mullerian hormone levels as predietor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 2009;92:1586-93.
37. Seifer DB, Baker VL, Leader B. Age-speeifie serum anti-Mullerian hormone values for 17,120 women presenting to fertility eenters within the United States. Fertil Steril 2011;95:747-50.
38. Shebl O, Elmer T, Sir A, Sehreirer-Leehner E, Mayer RB, Tews G, et al. Age-related distribution of basal serum AMH level in women of reproduetive age and a presumably healthy eoho-rt. Fertil Steril 2011;95:832-4.
39. Guidi GC, Salvagno GL. Referenee intervals as a tool for total quality management. Bioehem Med 2010;20:165-72.
40. Nelson SM, Messow MC, Wallaee AM, Fleming R, MeConnae-hie A. Nomogram for the deeline in serum antimullerian hormone: a population study of 9,601 infertility patients. Fertil Steril 2011;95:736-41.
41. Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallaee WHB. A validated model of serum anti-Mullerian hormone from eoneeption to menopause. PLoS ONE 2011;6:e22024.
42. Sowers MFR, Eyvazzadeh AD, MeConnell D, Yosef M, Jannaus-eh ML, Zhang D, et al. Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endoerinol Metab 2008;93:3478-83.
43. Faddy MJ, Gosden RG. A model eonforming the deeline in fol-liele numbers to the age of menopause in women. Hum Rep-rod 1996;11:1484-6.
44. van Montfrans JM, Hoek A, van Hooff MH, deKoning CH, Ton-eh N, Lambalk CB. Predietive value of basal folliele-stimulati-ng hormone eoneentrations in a general subfertility population. Fertil Steril 2000;74:97-103.
45. Tehrani FR, Solaymani-Dodaran M, Azizi F. A single test of antimullerian hormone in late reproduetive-aged women is a good predietor of menopause. Menopause 2009;16:797-802.
46. de Carvalho BR, Rosa e Silva AC, Rosa e Silva JC, dos Reis RM, Ferriani RA, Silva de Sa MF. Ovarian reserve evaluation: state of the art. J Assist Reprod Genet 2008;25:311-22.
47. Knauff EAH, Eijkemans MJC, Lambalk CB, ten Kate-Booij MJ, Hoek A, Beerendonk CCM. Anti-Mullerian hormone, inhibin B, and antral folliele eount in young women with ovarian failure. J Clin Endoerinol Metab 2009;94:786-92.
48. Barad DH, Weghofer A, Gleieher N. Comparing anti-Mullerian hormone (AMH) and folliele-stimulating hormone (FSH) as predietors of ovarian funetion. Fertil Steril 2009;91:1553-5.
49. Gleieher N, Weghofer A, Barad DH. Diseordanees between folliele stimulating hormone (FSH) and anti-Mullerian hormone (AMH) in female infertility. Available at: http://www.rbej.eom/eontent/8/1/64, Aeeessed June 17,2010.
50. Gleieher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Available at: http://www.rbej.eom/eontent/9/1/23, Aeeessed February 7,2011.
51. Jayap rakasan K, Campbell B, Hopkis son J, Joh nson I, Rai-ne-Fenning N. A prospeetive, eomparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the predietion of poor response to eontrolled ovarian stimulation. Fertil Steril 2010;93:855-64.
52. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of anti-Mullerian hormone in predietion ofouteome after IVF: eompa-rison with the antral folliele eount. Fertil Steril 2009;91:705-14.
53. Gleieher N, Weghofer A, Barad DH. Anti-Mullerian (AMH) defines, independent of age, low versus good livebirth ehanees in women with severely diminished ovarian reserve. Fertil Steril 2010;94:2824-7.
54. Diamanti-Kandarakis E. Polyeystie ova rian syndro me: pat-hophysiology, moleeular aspeets and elinieal implieations. Expert Rev Mol Med 2008;10;e3.
55. The Rotterdam ESHRE ASRM-sponsored PCOS Consensus Workshop Group: Revised 2003 eonsensus on diagnostie eri-teria and long-term health risks related to polyeystie ovary syndrome. Fertil Steril 2004;81:19-25.
56. Pigny P, Jonard J, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for an tral folliele eountfor definition of the polyeystie ovary syndrome. J Clin Endoerinol Metab 2006;91:941-5.
57. Rigon C, Andrisani A, Forzan M, DAntona D, Bruson A, Cosmi E, et al. Assoeiation study of AMH and AMHRII polymorphisms with unexplained infertility. Fertil Steril 2010;34:1244-8.
58. Oppelt P, Strissel PL, Kellermann A, Seeber S, Humeny A, Bee-kmann MW, Striek R. DNA sequenee varialions of the entire anti-Mullerian hormone (AMH) gene promoter and AMH pro lein expression in pa lien Is wilh the Mayer-Roki-tan sky-Kuster-Hau ser syndro me. Human Rep roduetion 2005;20:149-57.
59. Zenteno JC, Carranza-Lira S, Kofman-Alfaro S. Moleeular analysis ofthe anti-Mullerian hormone reeeptor. and galae-tose-1-phosphate uridyl transferase genes in patients with the Mayer-Rokitansky-Kuster-Hauser syndrome. Areh Gyne-eol Obstet 2004;269:270-3.
60. La Marea A, Volpe A. The anti-Mullerian hormone and ovarian eaneer. Hum Reprod Update 2007;13:265-73.
61. Long WQ, Ranehin V, Pautier P, Belville C, Denizot P, Cailla H, et.al. Deteetion of minimal levels of anti-Mullerian hormone during follow-up of patients with ovarian granulosa-eell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endoerinol Metab 2000; 85:540-4.
62. Wallaee WHB, Barr RD. Fertility preservation for girls and young women with eaneer: what are remaining ehallenges? Hum Rep rod Up da te 2010;16:614-6.
63. Bath LE, Wallaee WHB, Shaw MP, Fitzpatriek C, Anderson RA. Dep le tion of ova rian reser ve in you ng women after treatment for eaneer in ehildhood: deleelion by anli-Mullerian hor mo ne, in hi bin B and ova rian ul tra sou nd. Hum Rep rod 2003;18:2368-74.
64. Partrige AH, Ruddy KJ, Gelber S, Sehapira L, Abusief M, Meyer M, et al. Ovarian reserve in women who remain premeno-pausal after ehemotherapy for early stage breast eaneer. Fertil Steril 2010;94:638-44.
65. Hudson P, Douglas I, Donahoe P, Cate R, Epstein J, Pepinsky RB, MaeLaughlin D. An immunoassay to deteet human Mullerian inhibiting substanee in males and females during normal development. J Clin Endoerinol Metab 1990;70:16-22.
66. Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfie-ld M, VisserJA, et al. Development of a sensitive enzyme immunoassay for anti-Mullerian hormone (AMH) and the evaluation of potential elinieal applieations in males and females. Clin. Endoerinol (Oxf) 2005;63:267-73.
67. Kumar A, Kalra B, Patel A, MeDavid L, Roudebush WE. Development of a seeond generation anti-Mullerian hormone (AMH) ELISA. J Immunol Methods 2010;362:51-9.
68. Dodig S. Interferenees in quantitative immunoehemieal methods. Bioehem Med 2009; 19:50-62.
69. Wallaee AM, Faye SA, Fleming R, Nelson SR. A multieen-tre eval uation of the new Beekman Coulter anti-Mullerian hormone immunoassay (AMH Gen II). Ann Clin Bioehem 2011;48:370-3.
70. Seiaeovelli L, Seeehiero S, Zardo L, Plebani M. The role of the External Quality Assessment. Bioehem Med 2010;20:160-4.
71. UKNEQAS Newsletter. Available at: http://www.ukneqas.org.uk/doeuments/FINALNewsletterMareh2011forPartieipants(3).pdf, Aeeessed Mareh 2011.